Modernize your drug development with GMLs
Modernize your drug development approach by taking advantage of cutting edge functional genomics with Gene Mutation/Function Libraries (GMLs). Through a massively parallel mammalian cell in vivo process called the GigaAssay, Heligenics produces what is called a Gene Mutation/Function Library (“GMLs”). Each GML measures the impact of all possible amino acid substitutions in the target upon its molecular function in live human cells.
GMLs have several applications in the drug development pipeline: screening lead compounds, evaluating derivatives, characterizing compounds ready for trials, and optimizing trial design for approval. Eliminate safety concerns and low efficacy before a trial. These are the major factors that produce much higher risk for the drug development and approval process.